170 related articles for article (PubMed ID: 20367804)
1. Comparison of envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates.
Welker MW; Welsch C; Ochs D; Hofmann WP; Herrmann E; Piiper A; Hartmann RW; Zeuzem S; Sarrazin C; Kronenberger B
J Viral Hepat; 2011 Mar; 18(3):181-92. PubMed ID: 20367804
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.
Kronenberger B; Sarrazin C; Hofmann WP; von Wagner M; Herrmann E; Welsch C; Elez R; Rüster B; Piiper A; Zeuzem S
J Viral Hepat; 2004 Jul; 11(4):310-8. PubMed ID: 15230853
[TBL] [Abstract][Full Text] [Related]
3. Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.
Hofmann WP; Sarrazin C; Kronenberger B; Schönberger B; Bruch K; Zeuzem S
J Infect Dis; 2003 Mar; 187(6):982-7. PubMed ID: 12660945
[TBL] [Abstract][Full Text] [Related]
4. CD81 binding regions of hepatitis C virus remain conserved after liver transplantation.
Lyra AC; Fan X; Di Bisceglie AM
Braz J Infect Dis; 2004 Apr; 8(2):126-32. PubMed ID: 15361990
[TBL] [Abstract][Full Text] [Related]
5. Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver.
Young KC; Lin PW; Hsiao WC; Chang TT; Chang YC; Wu HL
J Med Virol; 2002 Oct; 68(2):188-96. PubMed ID: 12210407
[TBL] [Abstract][Full Text] [Related]
6. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
[TBL] [Abstract][Full Text] [Related]
7. Low density lipoprotein receptor transcripts correlates with liver hepatitis C virus RNA in patients with alcohol consumption.
Carrière M; Rosenberg AR; Conti F; Chouzenoux S; Terris B; Sogni P; Soubrane O; Calmus Y; Podevin P
J Viral Hepat; 2006 Sep; 13(9):633-42. PubMed ID: 16907851
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.
Bolcic F; Sede M; Moretti F; Westergaard G; Vazquez M; Laufer N; Quarleri J
Arch Virol; 2012 Apr; 157(4):703-11. PubMed ID: 22270759
[TBL] [Abstract][Full Text] [Related]
9. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
[TBL] [Abstract][Full Text] [Related]
10. [Late spontaneous elimination of HCV-RNA from mononuclear cells derived from peripheral blood in patients with chronic hepatitis C].
Majda-Stanisławska E; Sidorkiewicz M; Jóźwiak B; Pietrzak A; Brzezińska-Błaszczyk E
Przegl Epidemiol; 2006; 60(1):79-85. PubMed ID: 16758743
[TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes.
Hadlock KG; Lanford RE; Perkins S; Rowe J; Yang Q; Levy S; Pileri P; Abrignani S; Foung SK
J Virol; 2000 Nov; 74(22):10407-16. PubMed ID: 11044085
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection.
Chang TT; Young KC; Yang YJ; Lei HY; Wu HL
Hepatology; 1996 May; 23(5):977-81. PubMed ID: 8621178
[TBL] [Abstract][Full Text] [Related]
14. Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization.
Anjum S; Wahid A; Afzal MS; Albecka A; Alsaleh K; Ahmad T; Baumert TF; Wychowski C; Qadri I; Penin F; Dubuisson J
J Infect Dis; 2013 Dec; 208(11):1888-97. PubMed ID: 23908491
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
Allander T; Forns X; Emerson SU; Purcell RH; Bukh J
Virology; 2000 Nov; 277(2):358-67. PubMed ID: 11080483
[TBL] [Abstract][Full Text] [Related]
16. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets.
Yamada E; Montoya M; Schuettler CG; Hickling TP; Tarr AW; Vitelli A; Dubuisson J; Patel AH; Ball JK; Borrow P
J Gen Virol; 2005 Sep; 86(Pt 9):2507-2512. PubMed ID: 16099909
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
Zeuzem S; Lee JH; Roth WK
Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
[TBL] [Abstract][Full Text] [Related]
19. Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients.
Maggi F; Fornai C; Morrica A; Vatteroni ML; Giorgi M; Marchi S; Ciccorossi P; Bendinelli M; Pistello M
J Med Virol; 1999 Jan; 57(1):57-63. PubMed ID: 9890422
[TBL] [Abstract][Full Text] [Related]
20. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.
Zhao X; Tang ZY; Klumpp B; Wolff-Vorbeck G; Barth H; Levy S; von Weizsäcker F; Blum HE; Baumert TF
J Clin Invest; 2002 Jan; 109(2):221-32. PubMed ID: 11805134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
